Medizinische Universität Graz - Research portal
Svehlikova Eva |
Presentations at scientific and public conferences
Pieber, TR; Svehlikova, E; Fluhr, G; Höller, V; Gatschelhofer, C; Lackner, B; Magnes, C; Ratzer, M; Jezek, J; Howell, SJ; Gerring, D; Zakrzewski, L; Pillai, V; Murray, S
Pharmacokinetic and pharmacodynamic properties of highly concentrated insulin aspart AT278 U500 in overweight and obese people with type 2 diabetes
DIABETOLOGIA. 2024; 67: S534-S534.-60th Annual Meeting of the EASD; SEP 9-13, 2024; Madrid, SPAIN.
[Poster]
Web of Science
Svehlikova, E; Gatschelhofer, C; Höller, V; Fluhr, G; Lackner, B; Magnes, C; Ratzer, M; Gerring, D; Jezek, J; Howell, SJ; Zakrzewski, L; Pillai, V; Murray, S; Pieber, TR;
AT278 U500–Pharmacokinetic and pharmacodynamic properties of highly concentrated insulin aspart in overweight and obese people with type 2 diabetes.
Wien Klin Wochenschr (2024) . 2024; Supplement 18(136):S720--52. Jahrestagung der Österreichischen Diabetes Gesellschaft; NOV 14-16, 2024; Salzburg, AUSTRIA.
[Oral Communication]
Svehlikova, E; Gatschelhofer, C; Regittnig, W; Fluhr, G; Höller, V; Lackner, B; Eberl, A; Magnes, C; Pieber, TR
Glucagon as a potential promoter of sodium-glucose co-transporter 2 induced ketogenesis via effect on lipolysis
Wien Klin Wochenschr, . 2024; Supplement 18(136):S720--52. Jahrestagung der Österreichischen Diabetes
Gesellschaft; NOV 14-16, 2024; Salzburg, AUSTRIA.
[Oral Communication]
Svehlikova, E; Regittnig, W; Gatschelhofer, C; Höller, V; Fluhr, G; Lackner, B; Magnes, C; Eberl, A; Pieber, TR
Glucagon as a potential promoter of sodium-glucose co-transporter 2 induced ketogenesis via effect on lipolysis
DIABETOLOGIA. 2024; 67: S346-S347.-60th Annual Meeting of the EASD; SEP 9-13, 2024; Madrid, SPAIN.
[Poster]
Web of Science
Svehlikova, E; Regittnig, W; Gatschelhofer, C; Höller, V; Fluhr, G; Lackner, B; Magnes, C; Eberl, A; Pieber, TR
Dapagliflozin reduces endogenous glucose production during a period of acute insulin deprivation and development of ketoacidosis in people with type 1 diabetes
DIABETOLOGIA. 2024; 67: S128-S129.-60th Annual Meeting of the EASD; SEP 9-13, 2024; Madrid, SPAIN.
[Oral Communication]
Web of Science
Svehlikova, E; Regittnig, W; Gatschelhofer, C; Höller, V; Fluhr, G; Lackner, B; Magnes, C; Eberl, A; Pieber, TR
SGLT2 inhibition reduces endogenous glucose production during a period of acute insulin deprivation and development of ketoacidosis in people with type 1 diabetes
Wien Klin Wochenschr. 2024; Supplement 18(136):S721--52. Jahrestagung der Österreichischen Diabetes Gesellschaft; NOV 14-16, 2024; Salzburg, AUSTRIA.
[Oral Communication]
Monedeiro, F; Ehall, B; Prugger, EM; Zügner, E; Svehlikova, E; Pieber, T; Tiffner, K; Magnes, C; Sinner, F; Birngruber, T
Interstitial fluid metabolomics shows dupilumab effects in the treatment of atopic dermatitis.
J INVEST DERMATOL. 2023; 143(11):S352-S352.-5th Inflammatory Skin Disease Summit (ISDS); NOV 15-18, 2023; Vienna, AUSTRIA.
[Poster]
Web of Science
Pieber, T; Svehlikova, E; Urva, S; Haupt, A; Zhou, C; Coskun, T; Milicevic, Z; Pratt, EJ
Effect of tirzepatide on the counter-regulatory response to hypoglycaemia during a hypoglycaemic clamp in people with type 2 diabetes
DIABETOLOGIA. 2023; 66(SUPPL 1):S313-S313.-59th Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD); OCT 02-06, 2023; Hamburg, GERMANY.
[Poster]
Web of Science
PIEBER, TR; SVEHLIKOVA, E; URVA, S; HAUPT, A; ZHOU, C; COSKUN, T; MILICEVIC, Z; PRATT, EJ
Effect of Tirzepatide on the Counterregulatory Response to Hypoglycemia during a Hypoglycemic Clamp in People with Type 2 Diabetes.
Diabetes 2023;72(Supplement_1):129-OR. 2023; -23rd Scientific Session of American Diabetes Association; JUN 23-26, 2023; San Diego, USA.
[Oral Communication]
FullText
Svehlikova, E; Pieber, TR; Urva, S; Haupt, A; Zhou, CM; Coskun, T; Milicevic, Z; Pratt, EJ
Effect of Tirzepatide on the Counter-regulatory Response to Hypoglycaemia During a Hypoglycaemic Clamp in People with Type 2 Diabetes
WIEN KLIN WOCHENSCHR. Abstracts. 2023; 135(Suppl7):S783-S783.-51. Jahrestagung der ÖDG; NOV 16-18, 2023; Salzburg, AUSTRIA.
[Poster]
Web of Science
Tiffner, K; Ehall, B; Eberl, A; Bodenlenz, M; Pircher, T; Birngruber, T; Sinner, F; Svehlikova, E; Pieber, T
Dermal open flow microperfusion (dOFM) to monitor local tissue response after dupilumab treatment in lesional and non-lesional skin of atopic dermatitis patients
J INVEST DERMATOL. 2023; 143(11):S348-S348.-5th Inflammatory Skin Disease Summit (ISDS); NOV 15-18, 2023; Vienna, AUSTRIA.
[Poster]
Web of Science
Birngruber, T; Ehall, B; Tiffner, K; Svehlikova, E; Prietl, B; Raml, R; Pieber, T R; Sinner, F
Dermal Open Flow Microperfusion (dOFM) Reveals Mode of Action for Dupilumab in Dermal Tissue
Skin Forum Annual Meeting; JUN 21- 22, 2022; Malmö, SWEDEN. 2022.
[Poster]
Eberl, A; Ehall, B; Tiffner, K; Birngruber, T; Svehlikova, E; Pieber, T R
The impact of dupilumab treatment on cytokine levels in atopic dermatitis
51ST ANNUAL ESDR MEETING; SEP 28 - OCT 1, 2022; Amsterdam, NETHERLANDS. 2022.
[Poster]
Ehall, B; Eberl, A; Bodenlenz, M; Tiffner, K; Birngruber, T; Svehlikova, E; Pieber, T R,
Clinical trial using dermal open flow microperfusion (dOFM) elucidates mechanisms of dupilumab (Dupixent) on downstream signal pathways and indicates differences in local and systemic effects
51ST ANNUAL ESDR MEETING; SEP 28 - OCT 1, 2022; Amsterdam, NETHERLANDS. 2022.
[Oral Communication]
Pieber, TR; Arfelt, KN; Cailleteau, R; Thomsen, KMD; Hart, M; Mursic, I; Svehlikova, E; Urschitz, M; Haahr, H
Hypoglycaemia frequency and physiological response to double or triple doses of once-weekly insulin icodec versus once-daily insulin glargine in type 2 diabetes
DIABETOLOGIA. 2022; 65(SUPPL 1):S333-S333.-58th Annual Meeting of the European Association for the Study of Diabetes; Sep 20-23, 2022; Stockholm.
[Oral Communication]
Web of Science
Svehlikova, E; Arfelt, KN; Cailleteau, R; Deller, S; Thomsen, KMD; Hart, M; Mursic, I; Pieber, TR; Haahr, H
Hypoglycaemia frequency and physiological response to double or triple doses of once weekly insulin icodec vs. once-daily insulin glargine U100 in type 2 diabetes
WIEN KLIN WOCHENSCHR. 2022; 134(SUPPL 4):262-263.-50. ÖDG Jahrestagung; NOV 17-19, 2022; Salzburg, Austria.
[Poster]
Web of Science
Svehlikova, E; Hoeller, V; Urschitz, M; Wolf, M; Lackner, B; Magnes, C; Ratzer, M; Gerring, D; Jezek, J; Howell, SJ; Zakrzewski, L; Pillai, V; Ashcroft, N; Lawrence, F; Pieber, TR
Phase I study investigating PK and PD of highly concentrated insulin aspart AT278 U500
DIABETOLOGIA. 2022; 65(SUPPL 1):S209-S210.-58th EASD Annual Meeting; Sep 19-23, 2022; Stockholm, Sweden.
[Poster]
Web of Science
Svehlikova, E; Holler, V; Gumilar, J; Fluhr, G; Urschitz, M; Wolf, M; Lackner, B; Magnes, C; Ratzer, M; Gerring, DJ; Jezek, J; Howell, SJ; Zakrzewski, L; Pillai, V; Ashcroft, N; Lawrence, FJ; Pieber, TR
Phase I study investigating PK and -PD of highly-concentrated insulin aspart AT278 U500
WIEN KLIN WOCHENSCHR. 2022; 134(SUPPL 4):262-262.
[Oral Communication]
Web of Science
Svehlikova, E; Holler, V; Urschitz, M; Wolf, M; Lackner, B; Magnes, C; Ratzer, M; Gerring, D; Jezek, J; Howell, S; Zakrzewski, L; Pillai, V; Ashcroft, N; Lawrence, F; Pieber, T
AT278 (U500) - PK/PD AND SAFETY OF RAPID-ACTING CONCENTRATED INSULIN ASPART
DIABETES TECHNOL THE. 2022; 24: A39-A40.-ATTD 2022 ; APR 27-30, 2022; Barcelona, Spain.
[Oral Communication]
Web of Science
SVEHLIKOVA, E; NISS ARFELT, K; CAILLETEAU, R; DELLER, S; THOMSEN, KM; HART, M; MURSIC, I; PIEBER, TR; HAAHR, H
216-OR: Hypoglycemia Frequency and Physiological Response to Double or Triple Doses of Once-Weekly Insulin Icodec vs. Once-Daily Insulin Glargine in T2D
Diabetes. 2022; Vol 71(Sup 1):216-OR--82nd ADA Scientific Session; JUN 3-7, 2022; New Orleans, USA.
[Oral Communication]
FullText
Svehlikova, E; Augustin, T; Magnes, C; Gerring, D; Jezek, J; Howell, S; Zakrzewski, L; Ratzer, M; Gatschelhofer, C; Lawrence, F; Pieber, T
AT247-A NOVEL INSULIN ASPART FORMULATION WITH THE POTENTIAL TO CLOSE THE LOOP?
DIABETES TECHNOL THE. 2021; 23: A73-A73.-ATTD 2021; JUN 2-5, 2021; Virtual.
[Poster]
Web of Science
Mursic, I; Svehlikova, E; Regittnig, W; Augustin, T; Magnes, C; Eberl, A; Heise, T; Klein, O; Wolf, M; Urschitz, M; Brunner, M; Sourij, H; Pieber, T
Acid–Base Changes during Diabetic Ketoacidosis (DKA) in T1DM with and without SGLT2 Inhibitor (SGLT2i).
Diabetes 2020 Jun; 69(Supplement 1): 25-OR. 2020; 69(Suppl ):25-OR--80th ADA Scientific Session; JUN 12-16, 2020; Chicago, USA.
[Oral Communication]
FullText
Mursic, I; Svehlikova, E; Regittnig, W; Urschitz, M; Wolf, M; Brunner, M; Augustin, T; Magnes, C; Eberl, A; Heise, T; Klein, O; Sourij, H; Pieber, T
Acid-base changes during diabetic ketoacidosis in type 1 diabetes with/without SGLT2 inhibitor.
DIABETOLOGIA. 2020; 63(SUPPL 1):S272-S273.-56th Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD); SEP 21-25, 2020; ELECTR NETWORK.
[Oral Communication]
Web of Science
Nagy, B; Kovacs, G; Tornyos, A; Svehlikova, E; Foris, V; Nagaraj, C; Kwapiszewska, G; Pieber, TR; Olschewski, A; Olschewski, H
No indication of insulin resistance in idiopathic PAH with preserved physical activity.
EUR RESPIR J. 2020; 56:
Doi: 10.1183/13993003.congress-2020.1496
[Poster]
Web of Science
FullText
FullText_MUG
Nagy, BM; Kovacs, G; Tornyos, A; Svehlikova, E; Foris, V; Nagaraj, C; Kwapiszewska, G; Pieber, TR; Olschewski, A; Olschewski, H
No indication of insulin resistance in idiopathic PAH with preserved physical activity.
WIEN KLIN WOCHENSCHR. 2020; 132(19-20):619-619.
[Poster]
Web of Science
Pieber, TR; Augustin, T; Magnes, C; Gerring, DJ; Jezek, J; Howell, SJ; Zakrzewski, L; Lawrence, FJ; Svehlikova, E
Phase I Study Investigating the PD, PK, and Safety of AT247 in Comparison with Novorapid and Fiasp.
Diabetes 2020 Jun; 69(Supplement 1): 231-OR. 2020; 69(Suppl ):231-OR--80th ADA Scientific Session ; JUN 12-16, 2020; Chicago, USA.
[Oral Communication]
FullText
Svehlikova, E; Augustin, T; Lawrence, F; Gerring, D; Howell, S; Jezek, J; Zakrzewski, L; Magnes, C; Pieber, TR
Phase I study investigating the PD, PK and safety of AT247 in comparison to insulin aspart and fast insulin aspart.
DIABETOLOGIA. 2020; 63(SUPPL 1):S28-S28.-56th Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD); SEP 21-25, 2020; ELECTR NETWORK.
[Oral Communication]
Web of Science
Aberer, F; Pferschy, P; Tripolt, N; Sourij, C; Obermayer, AM; Pruller, F; Novak, E; Reitbauer, P; Kojzar, H; Prietl, B; Kofler, S; Brunner, M; Svehlikova, E; Stojakovic, T; Scharnagl, H; Oulhaj, A; Aziz, F; Riedl, R; Sourij, H
Hypoglycaemia leads to Platelet- and Coagulation Activation in Patients with Type 2 Diabetes under Metformin-Monotherapy - Results of hyperinsulinaemic hypoglycaemic Clamp-Study
WIEN KLIN WOCHENSCHR. 2019; 131(SUPPL 5):S461-S462.
[Poster]
Web of Science
Aberer, F; Pferschy, PN; Tripolt, N; Sourij, C; Obermayer, AM; Prüller, F; Novak, E; Reitbauer, P; Kojzar, H; Prietl, B; Kofler, S; Brunner, M; Svehlikova, E; Stojakovic, T; Scharnagl, H; Oulhaj, A; Aziz, F; Riedl, R; Sourij, H
Hypoglykämie führt zu einer Plättchen- und Gerinnungsaktivierung bei PatientInnen mit Typ 2 Diabetes unter Metformin-Monotherapie – Ergebnisse einer hyperinsulinämischen hypoglykämischen Clamp-Studie
Freier Vortrag. 2019; 131 (Suppl5) : 461-462.-47. Jahrestagung der Österreichischen Diabetes
Gesellschaft; NOV 21-23, 2019; Salzburg .
[Oral Communication]
FullText
Aberer, F; Pferschy, PN; Tripolt, NJ; Sourij, C;
Obermayer, A; Prüller, F; Novak, E; Reitbauer, P; Kojzar, H; Prietl, B; Kofler, S; Brunner, M; Svehlikova, E; Stojakovic, T; Scharnagl, H; Oulhaj, A; Aziz, F; Riedl, R; Sourij, H
Hypoglycaemia leads to delayed increase in platelet and coagulation activation markers in subjects with type 2 diabetes – results from a stepwise hypoglycaemic clamp study
Scientific Programme of the 5th CVOT Summit 2019. 2019; 28: 28-28.-CVOT Summit 2019; OCT 24-25, 2019; Munich, GERMANY.
[Poster]
FullText
Nagy, BM; Kovacs, G; Tornyos, A; Svehlikova, E; Foris, V; Nagaraj, C; Kwapiszewska, G; Pieber, TR; Olschewski, A; Olschewski, H
Is idiopathic pulmonary arterial hypertension caused by insulin resistance?
WIEN KLIN WOCHENSCHR. 2019; 131(19-20):526-526.
[Oral Communication]
Web of Science
Brunner, M; Haberlander, M; Svehlikova, E; Eberhard, K; Stach, E; Lipp, R; Obermayer-Pietsch, BM; Pieber, TR; Sourij, H
Assessment of Fasting Glucagon Levels in Subjects with Diabetes and Healthy Controls Using ELISA and RIA.
Proceedings of the 78th Scientific Sessions of the American Diabetes Association (ADA). 2018; -78th Scientific Sessions of the American Diabetes Association (ADA); JUN 22-26, 2018; Orlando, Florida, USA.
[Poster]
Pferschy, P; Tripolt, N; Url, J; Aberer, F; Hogenauer, C; Schreiber, F; Eherer, A; Sourij, C; Svehlikova, E; Obermayer, AM; Stadlbauer, V; Sourij, H
Endobarrier (R) gastrointestinal liner in obese subjects with type 2 diabetes - Sustainable effects on insulin sensitivity after explantation
WIEN KLIN WOCHENSCHR. 2018; 130: 374-374.
[Oral Communication]
Web of Science
Svehlikova, E; Merle,D; Sourij, H; Narath, S; Augustin, T; Magnes, C; Eberl, A; Urschitz, M; Wolf, M; Regittnig, W; Pieber, T
A Novel Insulin Depletion Protocol Combined with Stable Tracer Approach Assessing Intermediate Metabolism Can Be Efficiently Used for Investigation of the Development of Diabetic Ketoacidosis
The 3rd World Congress on Clinical Trials in Diabetes; DEC 3-4, 2018; Vienna, AUSTRIA. 2018.
[Poster]
Svehlikova, E; Sach-Friedl, S; Schadler, H-P; Augustin, T; Magnes, C; Eberl, A; Narath, S; Urschitz, M; Wolf, M; Treiber, G; Pieber, T
A Novel Stepwise eu-, Hyper-, and Hypoglycaemic Clamp Using Stable Tracer Method for Comparison of Glucose Fluxes and Lipolysis in Type 1 and Type 2 Diabetes Mellitus
3rd Wolrd Congress on Clinical Trials in Diabetes; DEC 3-4, 2018; Vienna, AUSTRIA. 2018.
[Poster]
Tripolt, NJ; Aberer, F; Pferschy, PN; Url, J; Högenauer, C; Schreiber, F; Eherer, A; Sourij, C; Svehlikova, E; Obermayer, AM; Stadlbauer-Köllner, V; Sourij, H
EndoBarrier® Gastrointestinal Liner in Obese Subjects with Type 2 Diabetes - Short and Midterm Effects on Glucose Metabolism
46. ÖDG Jahrestagung 2018; NOV 15-17; Salzburg, AUSTRIA. 2018.
[Oral Communication]
Tripolt, NJ; Aberer, F; Url, J; Pferschy, PN; Högenauer, C; Schreiber, F; Eherer, A; Sourij, C; Svehlikova, E; Obermayer, AM; Stadlbauer, V; Sourij, H;
Changes in insulin sensitivity and beta-cell function within 9 months after duodeno-jejunal bypass liner implantation in patients with type 2 diabetes
2nd Donau Symposium & 3rd CBmed Biomarker Conference 2018; MAR 14-16, 2018; Vienna, Park Hyatt Vienna. 2018.
[Oral Communication]
Brunner, M; Haberlander, M; Svehlikova, E; Lipp, R; Stach, L; Obermayer-Pietsch, B; Pieber, TR; Sourij, H
Comparison of Glucagon Values of healthy Study Participants and Patients with Diabetes Mellitus by means of ELISA and RIA
WIEN KLIN WOCHENSCHR. 2017; 129: 178-179.
[Oral Communication]
Web of Science
Brunner, M; Haberlander, M; Svehlikova, E; Lipp, R; Stach, L; Obermayer-Pietsch, B; Pieber, TR; Sourij, H
Vergleich von Glukagonwerten gesunder StudienteilnehmerInnen und PatientInnen mit Diabetes mellitus mittels ELISA und RIA.
Wiener klinische Wochenschrift; 2017; 129(Supplement 4): 178–179. 2017; -45. Jahrestagung der Österreichischen Diabetes Gesellschaft; NOV 16-18, 2017; Salzburg, AUSTRIA.
[Oral Communication]
Pferschy, P; Tripolt, N; Aberer, F; Url, J; Högenauer, C; Schreiber, F; Eherer, A; Svehlikova, E; Obermayer, A; Stadlbauer, V; Sourij, C; Sourij, H;
Endobarrier bei adipösen Personen mit Typ-2 Diabetes: Kurz- und mittelfristige Auswirkungen auf den Glukosestoffwechsel
18. Jahrestagung der Österreichischen Adipositas Gesellschaft; OCT 20-21, 2017; Tech Gate Vienna. 2017.
[Oral Communication]
Pferschy, PN; Tripolt, NJ; Aberer, F; Url, J; Högenauer, C; Schreiber, F; Eherer, A; Svehlikova, E; Obermayer, AM; Stadlbauer, V; Sourij, C; Sourij, H
Endobarrier in obese People with Type-2 Diabetes: Short- and Medium-term Effects on the Glucose Metabolism
WIEN KLIN WOCHENSCHR. 2017; 129(19-20):732-732.
[Poster]
Web of Science
Sach-Friedl, S; Augustin, T; Magnes, C; Ekardt, E; Eberl, A; Narath, S; Brunner, M; Korsatko, S; Svehlikova, E; Treiber, G; Pieber, TR;
Effect of dapagliflozin, saxagliptin, and the combination of both on glucagon, endogenous glucose production (EGP) and glycerol in patients with type 2 diabetes
DIABETOLOGIA. 2017; 60: S412-S412.-53rd Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD); SEP 11-15, 2017; Lisbon, PORTUGAL.
[Oral Communication]
Web of Science
Svehlikova, E; Sach-Friedl, S; Schadler, HP; Augustin, T; Magnes, C; Eberl, A; Narath, S; Urschitz, M; Wolf, M; Treiber, G; Pieber, TR
A novel stepwise eu-, hyper- and hypoglycaemic clamp using stable tracer method to compare glucose fluxes and lipolysis in type 1 and type 2 diabetes
DIABETOLOGIA. 2017; 60: S115-S116.-53rd Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD); SEP 11-15, 2017; Lisbon, PORTUGAL.
[Oral Communication]
Web of Science
Tripolt, N; Aberer, F; Pferschy, P; Sourij, C; Url, J; Hogenauer, C; Schreiber, F; Eherer, A; Svehlikova, E; Obermayer, AM; Stadlbauer, V; Sourij, H
Endobarrier (R) gastrointestinal bypass-liner in obese subjects with type 2 diabetes: short- and mid-term effects on glucose metabolism
WIEN KLIN WOCHENSCHR. 2017; 129: 161-161.
[Poster]
Web of Science
FullText
Tripolt, NJ; Aberer, F; Pferschy, P; Sourij, C; Url, J; Högenauer, C; Schreiber, F; Eherer, A; Svehlikova, E; Obermayer, M; Stadlbauer-Köllner, V; Sourij, H
Endobarrier® gastrointestinal bypass-liner in obese subjects with type 2 diabetes: Short- and mid-term effects on glucose metabolism
45. Jahrestagung der Österreichischen Diabetesgesellschaft (ÖDG); NOV 16-18; Salzburg. 2017.
[Poster]
Ghazi, N; Svehlikova, E; Tuca, A; Obermayer-Pietsch, B; Freisinger, J; Tadler, F; Pieber, TR; Sourij, H
Knochenstoffwechsel bei morbid adipösen PatientInnen nach einer Magenbypass-Operation
Wien Klin Wochenschr (2016). 2016; 128: 743-744.-17. Jahrestagung der Österreichischen Adipositas Gesellschaft; OCT 21-22, 2016; Innsbruck, AUSTRIA.
[Oral Communication]
FullText
Ghazi, N; Svehlikova, E; Tuca, A; Obermayer-Pietsch, B; Freisinger, J; Tadler, F; Pieber, TR; Sourij, H
Bone metabolism in morbid obese Patients after a Gastric Bypass Surgery
WIEN KLIN WOCHENSCHR. 2016; 128(19-20):743-744.
[Poster]
Web of Science
Muenzker, J; Svehlikova, E; Harger, A; Tuca, A; Obermayer-Pietsch, B; Freisinger, O; Fruhmann, J; Tadler, F; Pieber, T
Reduced adipose tissue inflammation is associated with diabetes remission after gastric bypass surgery
WIEN KLIN WOCHENSCHR. 2016; 128: S417-S417.-44. Jahrestagung der Österreichischen Diabetes Gesellschaft ; NOV 17-19, 2016; Salzburg, AUSTRIA.
[Oral Communication]
Web of Science
Harger, A; Muenzker, J; Tuca, A; Zachhuber, V; Svehlikova, E; Freisinger, O; Fruhmann, J; Tadler, F; Obermayer-Pietsch, B; Pieber, TR
Signifikant höhere Genexpressionen von Adipomyokin Irisin und browning-Faktor PRDM16 in subkutanem Fetttgewebe von Patienten mit Typ 2 Diabetes 1 Jahr nach Magenbypass-Operation (RYGB).
Jahrestagung 2015 der Österreichischen Diabetes Gesellschaft; NOV 19-21, 2015; Salzburg, Austria. 2015.
[Oral Communication]
Harger, A; Munzker, J; Kaineder, K; Tuca, A; Zachhuber, V; Freisinger, O; Fruhmann, J; Tadler, F; Obermayer-Pietsch, B; Svehlikova, E; Pieber, T
Adipomyokine irisin (FNDC5) and browning factor PRDM16 expression levels are increased in subcutaneous adipose tissue in obese patients with type 2 diabetes one year after bariatric surgery
WIEN KLIN WOCHENSCHR. 2015; 127: S146-S146.
[Oral Communication]
Web of Science
Harger, A; Münzker, J; Kaineder, K; Tuca, A; Zachhuber, V; Freisinger, Oana; Fruhmann, Johanna; Tadler, F; Svehlikova, E; Obermayer-Pietsch, B; Pieber, T;
Adipomyokine irisin (FNDC5) and browning factor PRDM16 expression levels are increased in subcutaneous adipose tissue in obese patients with type 2 diabetes one year after bariatric surgery.
Diabetes: New Insights into Molecular Mechanisms and Therapeutic Strategies. 2015; -Diabetes: New Insights into Molecular Mechanisms and Therapeutic Strategies; OCT 25-29; Kyoto, Japan.
[Poster]
Harger, A., Münzker, J., Tuca, A., Lindheim, L., Zachhuber, V., Obermayer-Pietsch, B., Fruhmann, J., Freisinger, O., Tadler, F., Svehlikova, E., Pieber T.R.;
Irisin expression in subcutaneous adipose tissue in obese patients with type 2 diabetes increases one year after bariatric surgery.
Deutscher Diabetes Kongress (DDG) 2015 ; Berlin, Deutschland. 2015.
[Oral Communication]
Harger, A., Münzker, J., Tuca, A., Zachhuber, V., Svehlikova, E., Freisinger, O., Fruhmann, J., Tadler, F., Obermayer-Pietsch, B., Pieber, T.R.;
Changes in microRNA profile in subcutaneous adipose tissue from T2DM patients following bariatric surgery.
3rd Helmholtz-Nature Medicine Diabetes Conference [Scientific Round Table Session]; Munich, Germany. 2015.
[Oral Communication]
Muenzker, J; Harger, A; Tuca, A; Lindheim, L; Zachhuber, V;
Svehlikova, E; Freisinger, O; Fruhmann, J; Tadler, F; Obermayer-
Pietsch, B; Pieber, TR
FNDC5 (irisin) expression is increased in subcutaneous adipose tissue
in obese patients with type 2 diabetes one year after bariatric surgery.
Diabetologia. 2015; 58(Suppl 1):S320-S320.-51st Annual Meeting of the European Association for the Study of Diabetes (EASD); SEP 14-18, 2015; Stockholm, SWEDEN.
[Poster]
Web of Science
Munzker, J; Harger, A; Kaineder, K; Tuca, A; Zachhuber, V; Freisinger, O; Fruhmann, J; Tadler, F; Svehlikova, E; Obermayer-Pietsch, B; Pieber, TR
Significantly higher Gene Expressions of Adipomyokin Irisin and browning-Factor PRDM16 in subcutaneous Fat Tissues of Patients with Type 2 Diabetes 1 Year after Gastric Bypass-Surgery.
WIEN KLIN WOCHENSCHR. 2015; 127(17-18):749-749.
[Poster]
Web of Science
Münzker, J; Harger, A; Kaineder, K; Tuca, A;Zachhuber, V; Freisinger, O; Fruhmann, J; Tadler, F; Svehlikova, E; Obermayer-Pietsch, B; Pieber, TR
Signifikant höhere Genexpressionen von
Adipomyokin Irisin und browning-Faktor PRDM16 in subkutanem Fettgewebe von Patienten mit Typ 2 Diabetes 1 Jahr nach Magenbypass-Operation.
16. Jahrestagung der österreichischen Adipositas Gesellschaft; OCT 23-24, 2015; Vienna, Austria. 2015.
[Oral Communication]
Münzker, J., Harger, A., Tuca, A., Lindheim, L., Zachhuber, V., Svehlikova, E., ., Freisinger, O., Fruhmann, J., Tadler, F., Obermayer-Pietsch, B., Pieber, T.R.;
Increased FNDC5 (irisin) expression in subcutaneous adipose tissue in obese patients with type 2 diabetes one year after bariatric surgery.
17th European Congress of Endocrinology 2015; May 16-20, 2015; Dublin, Republic of Ireland. 2015.
[Poster]
Münzker, J., Harger, A., Tuca, A., Lindheim., L., Zachhuber, V., Svehlikova, E., Freisinger, O., Fruhmann, J., Tadler, F., Obermayer-Pietsch, B., Pieber, T.R.;
FNDC5 (irisin) expression is increased in subcutaneous adipose tissue in patients with type 2 diabetes one year after bariatric surgery.
51th Annual Meeting of the European Diabetes Association (EASD); Stockholm, Sweden. 2015.
[Poster]
Münzker, J., Harger, A., Tuca, A., Zachhuber, V., Svehlikova, E., Freisinger, O., Fruhmann, J., Tadler, F., Obermayer-Pietsch, B., Pieber, T.R.;
FNDC5 (irisin) expression is increased in subcutaneous adipose tissue in obese patients with type 2 diabetes one year after bariatric surgery.
3rd Helmholtz-Nature Medicine Diabetes Conference [Scientific Round Table Session]; Munich, Germany. 2015.
[Oral Communication]
Munzker, J; Harger, AH; Tuca, A; Zachhuber, V; Svehlikova, E; Freisinger, O; Fruhmann, J; Tadler, F; Obermayer-Pietsch, B; Pieber, TR
Changes in microRNA profiles in subcutaneous adipose tissue from T2DM patients following bariatric surgery
WIEN KLIN WOCHENSCHR. 2015; 127: S147-S147.-ÖDG; Salzburg.
[Poster]
Web of Science
Svehlikova, E; Pieber, TR; Tuca, A; Obermayer-Pietsch, B; Freisinger, O; Tadler, F; Ernst, B; Wilms, B; Thurnheer, M; Schultes, B
PREOPERATIVE STIMULATED C-PEPTIDE LEVELS DO NOT PREDICT IMPROVEMENT OF GLUCOSE METABOLISM IN T2DM PATIENTS AFTER GASTRIC BYPASS SURGERY.
3rd World Congress on Interventional Therapies for Type 2 Diabetes and 2nd Diabetes Surgery Summit; SEP 28-30, 2015; London, UK. 2015.
[Poster]
Narath, SH; Libiseller, G; Fauland, A; Gander, E; Sourij, H; Kleb, U; Svehlikova, E; Pieber, TR; Sinner, FM; Magnes, C
A data driven approach to explore the link between metabolomics and diabetes relevant outcomes after bariatric surgery.
Proceedings of the 4th European Lipidomic Meeting. 2014; -4th European Lipidomic Meeting; SEP 22-24, 2014; Graz, AUSTRIA.
[Poster]
Narath, SH; Libiseller, G; Fauland, A; Gander, E; Sourij, H; Kleb, U; Svehlikova, E; Pieber, TR; Sinner, FM; Magnes, C
Short-term effects of bariatric surgery: investigating the link of
metabolomics and insulin resistance with a data driven approach.
Metabomeeting; SEP 10-12, 2014; London, UK. 2014.
[Poster]
Svehlikova, E; Pieber, TR; Höller, V; Obermayer-Pietsch, B; Freisinger, O; Tadler, F; Ernst, B; Wilms, B; Thurnheer, M; Schultes, B.
Effect of Diabetes Duration on Improvement of Glucose Metabolism After Gastric Bypass Surgery.
Diabetes. 2014; 63(Supp.1):A452-A452.-74th Scientific Sessions of the American Diabetes Association (ADA); JUN 13-17, 2014 ; San Francisco, CA, USA.
[Poster]
Svehlikova, E; Pieber, TR; Tuca, A; Obermayer-Pietsch, B; Freisinger, O; Tadler, F; Ernst, B; Wilms, B; Thurnheer, M; Schultes, B
ROUX-EN-Y GASTRIC BYPASS SURGERY RAPIDLY IMPROVES BETA CELL'S INSULIN PROCESSING IN SEVERELY OBESE TYPE 2 DIABETIC PATIENTS
OBES SURG. 2014; 24(7):1003-1003.-6th Congress of the International-Federation-for-the-Surgery-of-Obesity-and-Metabolic-Disorders, European-Chapter (IFSO-EC); APR 30-MAY 03, 2014; Brussels, BELGIUM.
[Oral Communication]
Web of Science
Svehlikova, E; Tuca, A; Höller, V; Mader, J; Obermayer-Pietsch, B; Freisinger, O; Tadler, F; Ernst, B; Wilms, B; Thurnheer, M; Schultes, B; Pieber, TR
Die Verbesserung der Betazellfunktion bei morbid adipösen Patienten mit Typ 2 Diabetes nach Magenbypassoperationen ist mit einer verbesserten Insulinverarbeitung in der Betazelle verbunden.
Wiener Klinische Wochenschrift. 2014; 126(S04):S185-S185.-42. Jahrestagung der Österreichischen Diabetes Gesellschaft (ÖDG); NOV 20-22, 2014; Salzburg, AUSTRIA.
[Oral Communication]
Web of Science
Svehlikova, E; Tuca, A; Höller, V; Obermayer-Pietsch, B; Freisinger, O; Tadler, F; Ernst, B; Wilms, B; Thurnheer, M; Schultes, B; Pieber, TR
Restoration of beta cell function in severely obese type 2 diabetic patients after gastric bypass surgery is accompanied by improved insulin processing.
Diabetologia. 2014; 57(Supp.1):S59-S59.-50th Annual Meeting of the European Diabetes Association (EASD) ; SEP 15-19, 2014; Vienna, AUSTRIA.
[Oral Communication]
Web of Science
Brandner, LM; Höller, V; Svehlikova, E; Leb-Stöger, U; Pieber, TR, Treiber, G;
Retrospective gender-medical differences in eating habits, comorbidities and laboratory parameters of obese patients before a surgical intervention for weight reduction
1st International Student Congress (ISC); JUN 4-6, 2013; Graz, Austria. 2013.
[Poster]
Höller, V; Brandner, LM; Svehlikova, E; Lind, A; Leb-Stöger, U; Pieber, TR; Treiber, G
Genderspezifische Unterschiede in den metabolischen Charakteristika von adipösen Patientinnen bei internistischer Evaluierung vor bariatrischen Eingriffen
WIENER KLINISCHE WOCHENSCHRIFT. 2013; 125(2 Supp):15-15.-41. Jahrestagung der Österreichischen Diabetes Gesellschaft; NOV 21-23, 2013; Salzburg, AUSTRIA.
[Poster]
Svehlikova, E; Pieber, TR; Horki, V; Obermayer-Pietsch, B; Freisinger, O; Tadler, F; Ernst, B; Wilms, B; Thurnheer, M; Schultes, B;
Improved Glucose Metabolism Early and 1 Year after Gastric Bypass Surgery Relies on Both Improved Insulin Sensitivity and Beta-Cell Function
Diabetes. 2013; 62(Supp 1):A477--73rd ADA Scientific Session; JUN 21-25, 2013; Chicago, IL, USA.
[Poster]
Svehlikova, E; Tuca, A; Höller, V; Obermayer-Pietsch, B; Freisinger, O; Tadler, F; Ernst, B; Wilms, B; Thurnheer, M; Schultes, B; Pieber, TR
Magenbypassoperationen führen zu einer raschen Verbesserung der Insulinverarbeitung in der Betazelle bei morbid adipösen Patienten mit Typ-2-Diabetes
WIENER KLINISCHE WOCHENSCHRIFT. 2013; 125(2 Supp):S5-S5.-41. Jahrestagung der Österreichischen Diabetes Gesellschaft; NOV 21-23, 2013; Salzburg, AUSTRIA.
[Oral Communication]
Horki, V; Tripolt, N; Svehlikova, E; Leb-Stoger, U; Pieber, T; Bock, G
Gender-specific Differences in adipose Patients at Introduction to the Adipositas-Ambulance
WIEN KLIN WOCHENSCHR. 2012; 124(17-18):658-658.
[Poster]
Web of Science
Horki, V; Tripolt, N; Svehlikova, E; Leb-Stöger, U; Pieber, TR; Bock, G
Geschlechtsspezifische Unterschiede der adipösen Patienten bei Vorstellung in der Adipositasambulanz
13. Jahrestagung der Österreichischen Adipositas Gesellschaft; SEP 28-29, 2012; Seggau, Austria. 2012.
[Poster]
Horki, V;Tripolt, N; Svehlikova, E; Leb-Stöger, U; Pieber, T; Bock, G;
Geschlechtsspezifische Unterschiede der adipösen Patienten bei Vorstellung in der Adipositasambulanz vor chirurgischem Eingriff zur Gewichtsreduktion
5. Jahrestagung der Österreichischen Gesellschaft für geschlechtsspezifische Medizin (ÖGGSM); Posterpreis
; 20.4.2012; Wien, AUSTRIA. 2012.
[Oral Communication]
Leb-Stöger, U; Haas, W; Köhler, G; Brodmann, M; Bock, G; Svehlikova, E; Mader, J; Pilger, E; Pieber, TR.
Diabetic foot clinic: Set-up of interdisciplinary cooperation: 1 year of evaluation
EWMA Journal. 2012; 12(2):92-92.-Europaean Wound Management Association (EWMA); May 23-25; Vienna, Austria.
[Oral Communication]
Svehlikova, E; Schultes, B; Ernst, B; Freisinger, O; Tadler, F; Pieber, TR:
Changes in glucose metabolism and incretins early and 1 year after gastric bypass surgery in morbidly obese patients with type 2 diabetes.
Wien Klin Wochenschr. 2012; 124(1 Supp):15-15.-40. Jahrestagung der Österreichischen Diabetes Gesellschaft; NOV 15-17, 2012; Salzburg, AUSTRIA.
[Oral Communication]
FullText
Svehlikova, E; Tuca, A; Horki, V; Obermayer-Pietsch, B; Freisinger, O; Tadler, F; Ernst, B; Wilms, B; Thurnheer, M; Schultes, B; Pieber, TR
Changes in the Glucose Metabolism early on and 1 Year after a Gastric Bypass Operation in morbidly adipose Patients with Type 2 Diabetes
WIEN KLIN WOCHENSCHR. 2012; 124(17-18):659-660.
[Poster]
Web of Science
Schultes, B; Ernst, B; Wilms, B; Thurnheer, M; Svehlikova, E; Zahiragic, S; Tuca, A; Obermayer-Pietsch, B; Freisinger, O; Pieber, TR
Early improvement of insulin sensitivity but not of insulin secretion in severely obese type 2 diabetic patients after gastric bypass surgery
Diabetes, Supplement 1. 2011; 60: A443--71st ADA Scientific Sessions; JUN 24-28, 2011; San Diego, CA, USA.
[Poster]
Schultes, B; Svehlikova, E; Ernst, B; Wilms, B; Thurnheer, M; Zahiragic, S; Tuca, A; Obermayer-Pietsch, B; Freisinger, O; Pieber, TR
Evidence against a major contribution of glucagon-like peptide 1 to the early improvement of glucose metabolism after gastric bypass surgery in severely obese patients with type 2 diabetes
European Group for the Study of Insulin Resistance (EGIR) Meeting; MAY 4-6, 2011; Geneva, Switzerland. 2011.
[Oral Communication]
Svehlikova, E; Schultes, B; Zahiragic, S; Freisinger, O; Tadler, F; Ernst, B; Wilms, B; Thurnheer, M; Obermayer-Pietsch, B; Pieber, TR
The improvement in glucose metabolism early after gastric bypass surgery is based primarily on an increase in insulin sensitivity independently of diabetes duration
WIEN KLIN WOCHENSCHR. 2011; 123: S12-S12.-39th Annual Conference of Austrian Diabetes Society; NOV 17-19, 2011; Salzburg, Austria.
[Oral Communication]
Web of Science
Svehlikova, E; Schultes, B; Zahiragic, S; Freisinger, O; Tadler, F; Ernst, B; Wilms, B; Thurnheer, M; Obermayer-Pietsch, B; Pieber, TR
The improvement in glucose metabolism early after gastric bypass surgery is based primarily on an increase in insulin sensitivity
WIEN KLIN WOCHENSCHR. 2011; 123(17-18):A39-A39.
[Oral Communication]
Web of Science
Svehlikova, E; Zahiragic, S; Pieber, TR; Tuca, A; Obermayer-Pietsch, B; Freisinger, O; Ernst, B; Wilms, B; Thurnheer, M; Schultes, B
Improved glucose metabolism early after gastric bypass surgery relies primarily on enhanced insulin sensitivity
Diabetologia (Supplement 1). 2011; 54: S82--47th European Association for the Study of Diabetes Annual Meeting; SEP 12-16, 2011; Lisbon, Portugal.
[Oral Communication]
Zahiragic, S; Svehlikova, E; Schweighofer, N; Tuca, A; Schultes, B; Thurnheer, M; Obermayer-Pietsch, B; Freisinger, O; Tadler, F; Pieber, TR
Gene expression in visceral and subcutaneous adipose tissue of morbidly obese subjects: an insight into the new Adipokines and inflammatory mediators
WIEN KLIN WOCHENSCHR. 2011; 123: S15-S15.-39th Annual Conference of Austrian Diabetes Society; NOV 17-19, 2011; Salzburg, Austria.
[Oral Communication]
Web of Science
Bock, G; Mader, JK; Kohler, G; Svehlikova, E; Horvath, K; Pieber, TR
Pseudo-hypoglycemia - a diagnostosche challenge in the investigation.
WIEN KLIN WOCHENSCHR. 2010; 122: S5-S5.
[Poster]
Web of Science
Schultes, B; Ernst, B; Wilms, B; Thurnheer, M; Svehlikova, E; Obermayer-Pietsch, BM; Pieber, TR
Restoration of beta cell function in severely obese type 2 diabetic patients after gastric bypass surgery
DIABETOLOGIA. 2010; 53: 775--46th EASD Meeting; SEP 24-29, 2010; Stockholm, Sweden.
[Poster]
Web of Science
Svehlikova, E; Schultes, B; Ernst, B; Wilms, B; Thurnheer, M; Obermayer-Pietsch, B; Pieber, TR
Changes in glucose metabolism and glucagon levels after gastric bypass surgery in morbidly obese patients with type 2 diabetes.
WIEN KLIN WOCHENSCHR. 2010; 122: S21-S21.-38. Jahrestagung der ÖDG; NOV 18-20, 2010; Salzburg, Austria.
[Poster]
Web of Science
Doll, WK; Regittnig, W; Korsatko, S; Lindpointner, S; Pichler, EM; Krusinova, E; Pieber, T; Ellmerer, M
Effect of the insertion method on the sensor response of a continuous subcutaneous glucose measuring system.
WIEN KLIN WOCHENSCHR. 2009; 121: S8-S8.- 37. Jahrestagung der Österreichischen Diabetesgesellschaft; NOV 19-21, 2009; Salzburg, AUSTRIA.
[Poster]
Web of Science
Doll, WK; Regittnig, W; Korsatko, S; Lindpointner, S; Pichler, EM; Krusinova, E; Pieber, TR; Ellmerer, M
Evaluation of the effect of different sensor insertion methods on the accuracy of a continuous glucose monitoring system
DIABETOLOGIA. 2009; 52: 927-- 45th EASD Annual Meeting; SEPT 29 - OCT 2; Vienna, AUSTRIA .
[Poster]
Web of Science
Pichler, EM; Ikeoka, D; Pachler, C; Mader, JK; Bock, G; Krusinova, E; Feichtner, F; Koehler, G; Pieber, T; Ellmerer, M
Serum and adipose tissue adipokine concentrations are affected by non-esterified fatty-acids in healthy individuals
DIABETOLOGIA. 2009; 52: 61--45th Meeting of the EASD (European Society for the Study of Diabetes); SEP 29 - OCT 2, 2009; Vienna, AUSTRIA.
[Oral Communication]
Web of Science
Ikeoka, D; Pachler, C, Mader, JK; Bock, G; Wutte, A; Krusinova, E; Feichtner, F; Köhler, G; Pieber, TR; Ellmerer; M
The effect of lipid-heparin infusion on systemic and locally stimulated inflammation in subcutaneous tissue of healthy volunteers.
Wiener Klinische Wochenschrift, Supplement2008; -36. Jahrestagung der Österreichischen Diabetesgesellschaft (ÖDG); NOV 20-22, 2008; Baden, AUSTRIA.
[Poster]